Updated: July 12, 2026
Funding raised
$1.3B
About the program
Program type
Investment stage
Investment focus areas
Description
We are an investment firm focused on advancing innovative medical solutions.
Location
Investment offer
Can lead rounds
Yes
Lead preference
Sometimes
Funding requirements
We invest in healthcare, medicine, and life science companies, supporting disruptive therapeutics.